• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600

AXA Framlington Health Fund - Z Income

Price: 222.20p|Change: 0.00 (0.14%)

This fund can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment

Before investing please read:

Key Investor Information Document (KIID)

Management

Name of companyAXA Investment Managers UK Ltd
Phone44 20 7003 2345
Websitewww.axa-im.com
Address22 Bishopsgate
-
London EC2N 4BQ
United Kingdom

Fund

DomicileGBR
Legal structureUnit Trust
UCITSYes
Inception date19/01/2015

Managers

Fund managerChris Eccles
Manager start date22/01/2024
BiographyChris Eccles is a research analyst who specialises in testing and regulatory affairs. He researches stocks globally and focuses on the Healthcare sector.Chris joined Impax in March 2019. He started working in the financial industry in 2011 as a research analyst at Morgan Stanley where he focused on European large-cap pharmaceuticals. In 2014, he became a partner at the hedge fund Kola Capital where he worked as a global equities analyst for three years before moving to Stifel in 2017 to work as a Healthcare Specialist.Chris achieved an MA (Oxon) Physiological Sciences First Class Honours, from the University of Oxford.
Fund managerCinney Zhang
Manager start date04/07/2023
Biography-

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.